About ThermoGenesis
ThermoGenesis is a company based in Rancho Cordova (United States) founded in 1986. The company has 41 employees as of December 31, 2022. ThermoGenesis offers products and services including AXP® II System, BioArchive® System, PXP-1000 System, and 3D Bag Set. ThermoGenesis operates in a competitive market with competitors including Multiply Labs, Shenzhen Shenyan Biotechnology, Cellular Origins, Cytera and Guangdong Bogong Medical Technology, among others.
- Headquarter Rancho Cordova, United States
- Employees 41 as on 31 Dec, 2022
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Thermogenesis Holdings, Inc.
-
Annual Revenue
$9.45 M (USD)-9.9as on Dec 31, 2023
-
Net Profit
-$17.98 M (USD)-59.49as on Dec 31, 2023
-
EBITDA
-$5.43 M (USD)-3.04as on Dec 31, 2023
-
Latest Funding Round
$3 M (USD), Post-IPO
Mar 22, 2023
- Investors
-
Employee Count
41
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of ThermoGenesis
ThermoGenesis is a publicly listed company on the OTC with ticker symbol THMO in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of ThermoGenesis
ThermoGenesis offers a comprehensive portfolio of products and services, including AXP® II System, BioArchive® System, PXP-1000 System, and 3D Bag Set.
System for obtaining bone marrow concentrates with minimal contamination.
Automated technology for preserving and protecting high-value cells.
Efficient separation of cord blood to retain stem cell viability.
Facilitates buffy coat transfer and cryoprotectant addition in a closed system.
People of ThermoGenesis
Unlock access to complete
Leadership Team
3 people
Operations Team
1 people
Sr. Team
1 people
Software Development Team
1 people
Unlock access to complete
Funding Insights of ThermoGenesis
Investors in ThermoGenesis
ThermoGenesis has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked |
Investor details for ThermoGenesis
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by ThermoGenesis
Investment portfolio details for ThermoGenesis
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - ThermoGenesis
Detailed financials for ThermoGenesis
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Thermogenesis Comparisons
Peer comparison for ThermoGenesis
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of ThermoGenesis
ThermoGenesis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Multiply Labs, Shenzhen Shenyan Biotechnology, Cellular Origins, Cytera and Guangdong Bogong Medical Technology, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Precision medicines are manufactured via robotic systems for cell therapies.
|
|
| Locked | Locked | Locked |
Automated cell processing systems are developed for gene therapies.
|
|
| Locked | Locked | Locked |
Automates cell therapy manufacturing through partnerships and robotics integration.
|
|
| Locked | Locked | Locked |
Automated cell culture devices using T-flasks and incubators are developed.
|
|
| Locked | Locked | Locked |
Robotic solutions for life science research are developed.
|
Detailed competitors of ThermoGenesis
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Thermogenesis
Complete news archive for ThermoGenesis
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ThermoGenesis
ThermoGenesis was founded in 1986 and raised its 1st funding round 23 years after it was founded.
ThermoGenesis is headquartered in Rancho Cordova, United States. It is registered at Rancho Cordova, California, United States.
As of Dec 31, 2022, the latest employee count at ThermoGenesis is 41.
Annual revenue of ThermoGenesis is $9.45M as on Dec 31, 2023.
ThermoGenesis is developing automated technologies for cell-based therapeutics and bio-processing. It offers automated clinical biobanking, point-of-care applications for cell-based therapeutics, and automation for immuno-oncology. It offers AXP BioArchive which provides automated isolation, collection and storage of cord blood stem cells. Another product, MXP allows automated processing of autologous peripheral or bone marrow-derived stem cells. CXP BioArchive is the automated manufacturing, expansion, and storage of cellular therapies for immuno-oncology. The company operates as a wholly owned subsidiary of Cesca Therapeutics.
ThermoGenesis's top competitors include Multiply Labs, Celltrio and Shenzhen Shenyan Biotechnology.
ThermoGenesis offers AXP® II System, BioArchive® System, PXP-1000 System, and 3D Bag Set.
Yes, ThermoGenesis is publicly traded on OTC under the ticker symbol THMO.
ThermoGenesis has 1 investor. Key investors include HHS.
The ticker symbol of ThermoGenesis is THMO on OTC.